{ "items": [ "\n\n
\n \n 3 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.
\n \n\n\n \n 2 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe launch of a new endoscopy service at the Oxford Experimental Medicine Clinical Research Facility (EMCRF) will enhance the collection of data for research projects at the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) and across the University of Oxford.
\n \n\n\n \n 2 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax\u2019s adjuvant is critical to reducing over half a million malaria-related deaths annually.
\n \n\n\n \n 25 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.
\n \n\n\n \n 25 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA study looking at the longer-term impact of COVID-19 has found that nearly a third of patients displayed abnormalities in multiple organs five months after infection, some of which have been shown through previous work to be evidence of tissue damage.
\n \n\n\n \n 25 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nYoung people\u2019s mental health deteriorated during COVID-19, with higher levels of depression and social, emotional and behavioural difficulties than before the pandemic hit, a comprehensive new study has shown.
\n \n\n\n \n 22 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nIn a study, recently published in Genomics Medicine, researchers from NDM\u2019s Wellcome Centre for Human Genetics and the CAMS Oxford Institute investigated the long-term impact of COVID-19 on immune cells.
\n \n\n\n \n 21 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nThe index establishes clusters through analysis of patent-filing activity and scientific article publication, documenting the geographical areas around the world with the highest density of inventors and scientific authors. This data forms part of the latest GII, which is due to be published in full later this month (Sept 27).
\n \n\n\n \n 20 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nNew research from the Nuffield Department of Primary Care Health Sciences at the University of Oxford, and the universities of Stirling and Aberdeen funded by the National Institute for Health and Care Research (NIHR), has shone a spotlight on the profound effect Long Covid can have on children and young people\u2019s school experience and wider lives.
\n \n\n\n \n 19 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe UK trial is the next step in the development of a vaccine to protect people against MERS \u2013 a deadly viral illness with no current vaccines and the potential to cause a pandemic.
\n \n\n\n \n 18 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe review, conducted jointly with researchers from Oxford University, the Royal Berkshire Hospital in Reading, and the Princess Anne Hospital in Southampton, included seven randomised controlled trials involving 2,464 women or couples who had been trying to conceive.
\n \n\n\n \n 18 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe MBRRACE-UK Collaboration, jointly led by Nuffield Department of Population Health\u2019s National Perinatal Epidemiology Unit (NPEU) and the University of Leicester\u2019s The Infant Mortality and Morbidity Studies (TIMMS) research group, has published a \u2018State of the Nation\u2019 report on perinatal deaths in babies born in the UK in 2021.
\n \n\n\n \n 13 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Trials\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time. Launched on the 4th of August 2023, the clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination.
\n \n\n\n \n 13 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA comprehensive new analysis has found that nicotine e-cigarettes, varenicline and cytisine are the most effective options currently available for helping smokers quit long-term (going at least six months without smoking).
\n \n\n\n \n 12 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nPolycystic ovarian syndrome (PCOS), a hormonal condition which affects how the ovaries work, is thought to affect 20% of women worldwide. Yet despite how common the condition is, and the serious effect it has on women\u2019s health, researchers still aren\u2019t completely sure what causes PCOS \u2013 let alone how best to manage and treat the condition.
\n \n\n\n \n 11 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 8 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at Nuffield Department of Population Health have found that having poor metabolic health was related to an increased risk of developing dementia in a study of more than 176,000 individuals.
\n \n\n\n \n 5 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA new study led by the Mead Group in the MRC Weatherall Institute of Molecular Medicine (Radcliffe Department of Medicine) has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant haematopoietic stem cells.
\n \n\n\n \n 4 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nHigh levels of two proteins at the time of COVID-19 have been found in patients who later experienced cognitive problems, including \u2018brain fog\u2019, giving a major clue as to one cause of their symptoms: blood clots.
\n \n\n\n \n 30 August 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards and Appointments\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Herman Waldmann FMedSci (Sir William Dunn School of Pathology) is one of four Oxford University researchers recognised today by the Royal Society.
\n \n\n